Alpha Cognition Inc. ACOG
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-09
Alpha Cognition Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | -221.7% | — | — |
| Net margin | -202.2% | — | — |
| FCF margin | -202.3% | — | — |
| Return on assets | -25.9% | -29.1% | -561.3% |
| Return on equity | -33.1% | -37.8% | 292.6% |
| Current ratio | 8.65 | 15.00 | 0.73 |
Source: SEC EDGAR filings · CIK 0001655923 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.